Stock GBIO GENERATION BIO CO.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Generation Bio Co.

Equities

GBIO

US37148K1007

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-26 EDT 		5-day change 1st Jan Change
2.8 USD -1.06% Intraday chart for Generation Bio Co. +3.70% +69.70%
05-13 Generation Bio Co. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-09 Generation Bio Co. Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms At the ASGCT 27th Annual Meeting CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
GL
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
GL
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting
GL
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
GL
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
GL
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
GL
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
GL
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
AQ
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GL
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms
GL
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms
AQ
Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results
GL
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform
GL
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform
AQ
Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA
GL
Phenylketonuria Pipeline, Emerging Drugs, Clinical Trials, and FDA Approvals 2023 (Updated)
AQ
Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit
GL
Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference 
GL
Generation Bio Reports Second Quarter 2023 Financial Results
GL
GENERATION BIO CO. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GBIO Stock
  4. News Generation Bio Co.
  5. Press Releases